Unilife Medical Solutions has appointed Mikron as its contracted supply partner for the development and supply of automated assembly systems to support the commercial production of the Unifill
FDA has accepted Actelion’s supplemental new drug application (sNDA) for an extension of indication for Zavesca (Miglustat) for the treatment of progressive neurological manifestations in adult and pediatric
Ecron Acunova, a full-service clinical research organization (CRO), has opened a new office in Moscow, Russia in October 2009. Galyna Andriyko has been named as General Manager. She
“Heart failure is one of the most costly medical conditions in the world, with 37% of US Medicare dollars alone spent on heart conditions each year,” said Michael
AstraZeneca has submitted a New Drug Application (NDA) to the FDA for Ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients
In addition, each party has received distribution rights to certain products supplied by the other party. Terms of the settlement include the following: The grant to OraSure of
Quark Pharmaceuticals has reported that four of its siRNA R&D platform based programs have met clinical development milestones. Patient enrollment was completed in three clinical studies and a
As part of the agreement, Asuragen will pursue CE marked-IVD registration in Europe and regulatory clearance in the US. The diagnostic test will then be distributed by Life
SinoFresh Healthcare has reported the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with
GlaxoSmithKline (GSK) seeks to shift a part of its Relenza drug manufacturing operations to China. The company’s strategic intent is to make available its flu drug, Relenza to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.